HiloProbe AB

Personalizing colorectal cancer diagnostics and prognosis.
Colorectal cancer is the third most common cancer worldwide. Half of all patients die from the disease, despite available treatments. HiloProbe is developing ColoNode®- a highly accurate biomarker test, to identify each patient’s need of treatment after surgery for colorectal cancer.

 

 

Contact details
Tvistevägen 48 C, 907 36 Umeå